Dick Menzies - Epidemiology

Author Information

Dick Menzies is a prominent researcher affiliated with the Respiratory Epidemiology and Clinical Research Unit at the Montreal Chest Institute, McGill International TB Centre, McGill University Health Centre Research Institute, and the Department of Epidemiology and Biostatistics at McGill University in Montréal, QC, Canada.

Research Contributions

Dick Menzies has made significant contributions to the field of epidemiology, particularly focusing on tuberculosis (TB) and respiratory diseases. In 2022 alone, he has published numerous papers addressing various aspects of TB, including infection and disease in healthcare workers, drug-resistant TB, TB diagnosis, preventive treatment in adults, and the implementation of specific TB treatment regimens. His work also extends to cost-effectiveness and budget impact analyses for TB treatment in Brazil, the safety of prolonged treatment with bedaquiline, and the adequacy of rapid antigen-detection testing for SARS-CoV-2. His extensive research output underscores his pivotal role in advancing the understanding and management of TB and other respiratory infections.

Aliases

Dick Menzies is also known by other names including D. Menzies and D Menzies.

Publication and Citation Metrics

Metric	Value
Total Citation Count	26,350
h-index	80
Total Number of Papers	435
Recent Publications (2022)	10

Publications:

Mycobacterium tuberculosis infection and disease in healthcare workers in a tertiary referral hospital in Bandung, Indonesia

DOI: 10.1177/17571774211046887

Year: 2022

Chapter 8: Drug-resistant tuberculosis

DOI: 10.1080/24745332.2022.2039499

Year: 2022

Chapter 4: Diagnosis of tuberculosis infection

DOI: 10.1080/24745332.2022.2036503

Year: 2022

Chapter 6: Tuberculosis preventive treatment in adults

DOI: 10.1080/24745332.2022.2039498

Year: 2022

Safety of prolonged treatment with bedaquiline in programmatic conditions

DOI: 10.1183/23120541.00685-2021

Year: 2022

Scaling up investigation and treatment of household contacts of tuberculosis patients in Brazil: a cost-effectiveness and budget impact analysis

DOI: 10.1016/j.lana.2021.100166

Year: 2022

Implementing the 4R and 9H regimens for TB preventive treatment in Indonesia

DOI: 10.5588/ijtld.21.0318

Year: 2022

Clinical standards for the diagnosis, treatment and prevention of TB infection

DOI: 10.5588/ijtld.21.0753

Year: 2022

Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis.

DOI: 10.1093/cid/ciac322

Year: 2022

Adequacy of serial self-performed SARS-CoV-2 rapid antigen-detection testing for longitudinal mass screening in the workplace

DOI: 10.1101/2022.02.10.22270805

Year: 2022

What are the Challenges of Using QlikView in Epidemiology?

What Are the Environmental Benefits?

How Can AMR be Prevented and Controlled?

How is Stratification Conducted?

How Do Bacteria Colonize the Human Body?

How Can We Improve Measurement Accuracy?

What Ethical Considerations Should Be Kept in Mind?

What are the Challenges in Setting Environmental Standards?

What Are Some Key Digital Skills for Epidemiologists?

What Role Does the FDA Play in Drug Approval?

Partnered Content Networks

Relevant Topics